You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Are you in a betting pool for how long the government shutdown will last? Send your guesses and news tips to [email protected] or John_Wilkerson.07…
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. I’ve started the week confused. Were ACIP’s recommendations modest or a worrisome break from established vaccine policy? Will the government shut down? Does the…
WASHINGTON — Congress is again discussing the Trump administration’s plan to force drug companies to lower their U.S. prices, at least behind the scenes. Congressional staffers and health policy experts from major think tanks held a closed-door meeting to discuss policy options that would peg U.S. prices for drugs to what other countries pay, called…
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Congress returns today from a long August recess. Put on your sneakers. We’re about to hit the ground running. Send news tips to [email protected]…
WASHINGTON — President Trump may aggressively negotiate lower drug prices in Medicare using a program that Democrats created and Trump rarely mentions in public. Since his first term, Trump has demanded that drugmakers charge Americans lower prices for pharmaceuticals, on par with those available in other wealthy countries, a policy often referred to as most-favored…
WASHINGTON — A handful of drug companies have formed a group to present lawmakers with research on what the industry sees as the negative impacts of Medicare drug price negotiations, according to lobbying records. The group is called the IRA Watchdog after the Inflation Reduction Act, which directed Medicare to negotiate the prices for some…
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. I was reminded recently of why I dig mass transit upon overhearing the train conductor and two middle-aged men engaged in a serious talk…